<DOC>
	<DOCNO>NCT00196612</DOCNO>
	<brief_summary>The combination two nucleoside analogue one protease inhibitor highly active antiretroviral therapy ( HAART ) HIV infect adult . In undetectable viral load , daily combination FTC , ddI , efavirenz would easier take , less side effect efficacy . The aim study evaluate daily combination present efficacy HAART therapy less side effect well adherence .</brief_summary>
	<brief_title>Once Daily Antiretroviral Therapy HIV Infected Adults Treated With HAART</brief_title>
	<detailed_description>The combination two nucleoside analogue one protease inhibitor highly active antiretroviral therapy ( HAART ) HIV infect adult , side effect great number pill induce less adherence therapy . Once daily combination lower number pill could easy take , great adherence , less side effect , efficacy . 355 patient recruit study , randomize two treatment group : maintenance HAART therapy versus change daily combination FTC , ddI , efavirenz , 48 week . The primary end-point viral success maintain 48 week . Secondary end-point safety adherence . The trial prolong total 48 week .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Didanosine</mesh_term>
	<mesh_term>Efavirenz</mesh_term>
	<mesh_term>Emtricitabine</mesh_term>
	<criteria>HIV infect adults Antiretroviral treatment since 6 month , two nucleoside analogue one two protease inhibitor CD4 cell count 100/mm3 HIV RNA 400 copies/ml since 6 month Signed write informed consent Previous treatment non nucleoside analogue , ddI alone Pregnancy Alcool abuse Acute infection , past neurological pancreatic disease , biological abnormality Chemotherapy immunotherapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2005</verification_date>
	<keyword>HIV Infections</keyword>
	<keyword>Reverse Transcriptase Inhibitors</keyword>
	<keyword>Treatment simplification</keyword>
</DOC>